17001 |
Manual sputum culture testing, negative |
9,00 |
17002 |
Breastmilk culture test |
14,00 |
17006 |
Urine culture test, manual, negative |
5,00 |
17010 |
Automated blood culture testing (aerobes and anaerobes), negative |
23,90 |
17011 |
Manual blood culture testing (aerobes and anaerobes), negative |
12,00 |
17012 |
Automated blood culture testing for children up to 5 years old, negative |
14,50 |
17013 |
Manual blood culture testing for children up to 5 years old, negative |
12,00 |
17018 |
Purulent exudate culture, negative |
12,00 |
17019 |
Aerobic wound culture, negative |
6,00 |
17020 |
Eye culture, negative |
6,00 |
17021 |
Ear culture, negative |
8,90 |
17022 |
Nasal swab for staphylococcus aureus, negative |
6,00 |
17024 |
Throat swab culture for hemolytic streptococci, negative |
5,00 |
17025 |
Throat swab culture for diphtheria causative agent, negative |
9,00 |
17026 |
Throat swab culture for pertussis causative agent, negative |
5,00 |
17027 |
Gonococcal culture, negative |
11,50 |
17028 |
Genital culture, negative |
8,00 |
17029 |
Sperm, prostate secretion culture, negative |
10,00 |
17032 |
Stool diagnostic culture, negative |
15,00 |
17033 |
Stool preventive culture, negative |
7,00 |
17038 |
Microscopic examination of skin, nails and hair for fungi |
6,00 |
17039 |
Skin, nails, hair culture for fungi, negative |
6,50 |
17040 |
Microscopy of various testing materials by Ziehl-Neelsen (or other staining methods) to determine acid-resistant bacteria |
5,00 |
17041 |
Female genital discharge microscopy |
5,00 |
17042 |
Male genital discharge microscopy |
5,00 |
17043 |
Bacterial vaginosis test for sialidase activity |
10,00 |
17044 |
Microscopy of pathologic materials, Gram staining |
5,00 |
17045 |
Antimicrobial sensitivity test by disc diffusion (6 discs) |
5,50 |
17046 |
Antimicrobial sensitivity test by disc diffusion (12 discs) |
7,00 |
17050 |
Antimicrobial sensitivity test by disc diffusion (automated system) |
12,00 |
17051 |
E-test for determination of MIC (mg/ml) of antimicrobial medicine (one bacterium – one medicine) |
12,00 |
17052 |
Determination of MIC (mg/ml) of antimicrobial medicine by automated dilution system |
27,10 |
17053 |
E-test for determination of Candida susceptibility to antifungal drugs (one drug for one culture) |
12,00 |
17054 |
Enterobacteriaceae identification at the level of genus |
5,00 |
17055 |
Enterobacteriaceae identification at the level of species |
11,00 |
17056 |
Shigella identification at the level of species |
11,00 |
17057 |
Salmonella identification at the level of genus |
8,90 |
17058 |
Salmonella identification at the level of species |
20,00 |
17059 |
Yersinia identification at the level of species |
15,00 |
17060 |
Enteropathogenic Escherichia identification at the level of species |
14,00 |
17061 |
Campylobacteria identification |
10,00 |
17062 |
Vibrio identification at the level of species |
25,50 |
17063 |
Clostridium difficile (C. difficile) isolation and identification |
22,00 |
17064 |
Staphylococcus aureus (S.aureus) identification |
6,00 |
17065 |
Detection of Staphylococcus aureus (S.aureus) enterotoxin by latex agglutination |
34,00 |
17066 |
Automated detection of methicillin-resistant S.aureus |
19,90 |
17067 |
Legionella identification |
15,00 |
17068 |
Immunochromatographic assay for rotavirus |
7,00 |
17069 |
Immunochromatographic assay for adenovirus |
7,00 |
17070 |
Streptococcus, alpha- hemolytic streptococcus identification at the level of species in blood cultures |
15,00 |
17071 |
Beta hemolytic streptococcus identification |
12,90 |
17072 |
Streptococcus pneumoniae identification |
12,50 |
17073 |
Meningococcus and gonococcus identification |
15,00 |
17074 |
Enterococcus identification at the level of genus |
7,00 |
17075 |
Enterococcus identification at the level of species |
15,00 |
17076 |
Haemophilus identification |
12,50 |
17077 |
Identification of pseudomonas at the level of species |
4,50 |
17078 |
Identification of pseudomonas and other biochemically inactive bacteria |
10,00 |
17079 |
Identification of listeria species |
16,00 |
17080 |
Identification of diphtheria causative agent |
12,00 |
17081 |
Identification of pertussis causative agent |
17,00 |
17082 |
Identification of tuberculosis mycobacteria by radiometric method |
30,00 |
17083 |
Anaerobic identification at the level of genus |
8,00 |
17084 |
Anaerobic identification at the level of species |
16,00 |
17085 |
Detection of the genus Candida by growing on chromogenic agar |
2,50 |
17086 |
Detection of the genus Candida by testing |
7,00 |
17087 |
E.coli O157 identification Yersinia pseudotuberculosis, Yersinia enterocolytica 03 ir 09 |
10,00 |
17088 |
Detection of Yersinia pseudotuberculosis, Yersinia enterocolytica antibodies 03 and 09 by indirect haemagglutination with appropriate antigens |
50,00 |
17089 |
Ureaplasma urealyticum and Mycoplasma hominis identification and antibiotic suspectability testing |
21,00 |
17090 |
Widal test |
8,00 |
17091 |
Wright-Hedelson’s reaction |
17,00 |
17092 |
Microagglutination testing to detect leptospirosis |
16,50 |
17093 |
Detection of antibodies against tularemia causative agent by agglutination |
18,00 |
17094 |
Detection of antibodies against brucella causative agent by agglutination |
18,00 |
17095 |
Detection of antibodies against brucella causative agent by enzyme immunoassay |
84,40 |
17096 |
Detection of IgA antibodies against pertussis causative agent |
14,00 |
17097 |
Detection of IgG antibodies against pertussis causative agent |
15,00 |
17098 |
Detection of IgM antibodies against pertussis causative agent |
14,00 |
17099 |
Detection of IgA antibodies Helicobacter pylori |
15,00 |
17100 |
Detection of IgG antibodies Helicobacter pylori |
15,00 |
17101 |
Detection of IgA antibodies Y.enterocolitica |
19,00 |
17102 |
Detection of IgG antibodies Y.enterocolitica |
19,00 |
17103 |
Detection of Clostridium difficile (C. difficile) toxin A in stools by latex agglutination |
16,00 |
17104 |
Detection of Mycoplasma pneumoniae IgA antibodies by enzyme immunoassay |
12,00 |
17105 |
Detection of Mycoplasma pneumoniae IgM antibodies by enzyme immunoassay |
12,00 |
17106 |
Detection of Mycoplasma pneumoniae IgM antibodies by immunoblotting |
48,00 |
17107 |
Detection of Mycoplasma pneumoniae IgG antibodies by enzyme immunoassay |
13,00 |
17108 |
Detection of Mycoplasma pneumoniae DNA |
61,50 |
17109 |
Detection of Mycoplasma pneumoniae antigen by immunofluorescence assay |
12,00 |
17110 |
Detection of Mycoplasma pneumoniae by latex agglutination in nasopharyngeal swabs |
27,00 |
17111 |
Detection of Mycoplasma hominis antigen by immunofluorescence assay |
11,90 |
17112 |
Detection of Ureaplasma urealyticum antigen by immunofluorescence assay |
11,90 |
17113 |
Detection of Chlamydia pneumoniae IgM antibodies by enzyme immunoassay |
14,90 |
17114 |
Detection of Chlamydia pneumoniae IgG antibodies by enzyme immunoassay |
14,90 |
17115 |
Detection of Chlamydia pneumoniae IgA antibodies by enzyme immunoassay |
15,00 |
17116 |
Detection of Chlamydia pneumoniae antigen by immunofluorescence assay |
12,00 |
17117 |
Detection of Chlamydia trachomatis antigen by immunofluorescence assay |
11,00 |
17118 |
Automated identification of anaerobic species |
15,00 |
17119 |
Fungi identification by species |
13,00 |
17120 |
Detection of heterophile antibodies for infectious mononucleosis by semi-quantitative latex agglutination |
4,90 |
17121 |
Detection of anti – EBBA IgG EBV virus IgM antibodies (anti – EBV IgM) by enzyme immunoassay |
8,00 |
17122 |
Detection of anti – EBBA IgG EBV virus IgG antibodies (anti – EBV IgG) by enzyme immunoassay |
8,00 |
17123 |
Detection of anti – EBBA IgG by enzyme immunoassay |
9,00 |
17124 |
Detection of EBV antibodies by immunoblotting |
48,00 |
17125 |
Detection of Cytomegalovirus (CMV) IgM by enzyme immunoassay |
20,00 |
17126 |
Detection of Cytomegalovirus (CMV) IgM by immunofluorescence assay |
29,00 |
17127 |
Detection of Cytomegalovirus (CMV) IgM by immunoblotting |
20,00 |
17128 |
Detection of Cytomegalovirus (CMV) IgG by enzyme immunoassay |
18,00 |
17129 |
Detection of Cytomegalovirus (CMV) IgG by immunofluorescence assay |
21,00 |
17130 |
Cytomegalovirus (CMV) IgG avidity testing |
28,00 |
17131 |
Cytomegalovirus (CMV) isolation from urine |
48,00 |
17132 |
Cytomegalovirus (CMV) isolation |
48,00 |
17133 |
Cytomegalovirus (CMV) isolation by titer |
60,00 |
17134 |
Cytomegalovirus (CMV) pp65 detection in leucocytes |
37,00 |
17135 |
Cytomegalovirus (CMV) DNA qualitative testing |
65,50 |
17136 |
Adeno virus IgM/IgG antibodies by enzyme immunoassay |
28,00 |
17137 |
Detection of Herpes simplex virus 1/2 (HSV 1/2) IgM by enzyme immunoassay |
14,00 |
17138 |
Detection of Herpes simplex virus 1 (HSV 1) IgG by enzyme immunoassay |
12,00 |
17139 |
Detection of Herpes simplex virus 2 (HSV 2) IgG by enzyme immunoassay |
12,00 |
17140 |
Herpes simplex virus (HSV) isolation and typing |
39,00 |
17141 |
Herpes simplex 1/2 (HSV1/2) DNA detection in cerebrospinal fluid |
170,00 |
17142 |
Detection of Varicella zoster virus (VZV) IgM |
23,00 |
17143 |
Detection of Varicella zoster virus (VZV) IgG |
18,00 |
17144 |
Varicella zoster virus (VZV) isolation |
48,00 |
17145 |
Detection of Hepatitis A virus (HAV) IgM by enzyme immunoassay |
18,00 |
17146 |
Detection of Hepatitis A virus (HAV) IgG/IgM by enzyme immunoassay |
18,00 |
17147 |
Detection Hepatitis A virus (HAV) IgG (postvaccination) |
27,00 |
17148 |
Detection of Hepatitis B virus (HBV) HBs Ag antigen by enzyme immunoassay |
7,00 |
17149 |
Hepatitis B virus (HBV) HBs Ag antigen neutralization reaction |
21,00 |
17150 |
Detection of Hepatitis B virus (HBV) HBcor antibodies by enzyme immunoassay |
15,00 |
17151 |
Detection of Hepatitis B virus (HBV) IgM (Hbcor IgM) antibodies by enzyme immunoassay |
25,00 |
17152 |
Detection of Hepatitis B virus (HBV) HBe antibodies by enzyme immunoassay |
10,00 |
17153 |
Detection of Hepatitis B virus (HBV) HBe Ag antigen by enzyme immunoassay |
10,00 |
17154 |
Hepatitis B virus (HBV) HBcor Ag antigen |
30,00 |
17155 |
Detection Hepatitis B virus (HBV) HBs antibodies by enzyme immunoassay |
12,00 |
17156 |
Hepatitis B virus (HBV) DNA qualitative testing without final product hybridization |
53,00 |
17157 |
Hepatitis B virus (HBV) qualitative testing with hybridization |
85,00 |
17158 |
Hepatitis B virus (HBV) DNA quantitative testing |
50,00 |
17159 |
Detection of Hepatitis C virus (HCV) Ag by enzyme immunoassay |
17,00 |
17160 |
Detection of Hepatitis C virus (HCV) antibodies |
15,00 |
17161 |
Hepatitis C virus (HCV) IgG by enzyme immunoassay |
40,00 |
17162 |
Hepatitis C virus (HCV) IgG by immunoblotting |
49,00 |
17163 |
Hepatitis C virus (HCV) RNA qualitative testing without final product hybridization |
55,00 |
17164 |
Hepatitis C virus (HCV) RNA qualitative testing with final product hybridization |
115,00 |
17165 |
Hepatitis C virus (HCV) RNA quantitative testing |
65,00 |
17166 |
Determination of Hepatitis C virus (HCV) genotype |
125,00 |
17167 |
Detection of human immunodeficiency virus (HIV) antigen by enzyme immunoassay |
12,00 |
17168 |
Tests of human immunodeficiency virus 1/2 (HIV 1/2) antibodies (with HIV1 O) |
5,00 |
17169 |
Detection of human immunodeficiency virus 1/2 (HIV 1/2) antibodies and p24 Ag by enzyme immunoassay |
9,00 |
17170 |
Detection of human T-cell lymphotropic virus 1/2 (HTLV 1/2) antibodies |
7,00 |
17171 |
Parainfluenza virus isolation and differentiation |
55,00 |
17172 |
Parotitis virus isolation |
28,00 |
17173 |
Detection of respiratory syncytial virus (RSV) by enzyme immunoassay |
13,00 |
17174 |
Detection of Hanta virus IgG by enzyme immunoassay |
13,00 |
17175 |
Detection of Rubella virus IgG by enzyme immunoassay |
10,00 |
17176 |
Detection of Rubella virus IgM by enzyme immunoassay |
14,00 |
17177 |
Rubella virus IgG avidity testing |
30,00 |
17178 |
Detection of Rubella IgG by immunofluorescence assay |
17,00 |
17179 |
Detection of Rubella IgM by immunofluorescence assay |
19,00 |
17180 |
Rubella virus isolation |
48,00 |
17181 |
Detection of tick-borne encephalitis IgM antibodies by enzyme immunoassay |
14,00 |
17182 |
Detection of tick-borne encephalitis IgG antibodies by enzyme immunoassay |
14,00 |
17183 |
Detection of Roto virus Ag by agglutination |
23,00 |
17184 |
Detection of Adeno virus Ag by agglutination |
27,00 |
17185 |
Detection of Parvo virus B19 IgM by enzyme immunoassay |
25,00 |
17186 |
Detection of Parvo virus B19 DNA by qualitative method |
30,00 |
17187 |
Detection of lymphocytic choriomeningitis virus IgG by immunofluorescence assay |
10,00 |
17188 |
Isolation of lymphocytic choriomeningitis virus |
39,00 |
17189 |
Detection of high-risk types of human papillomavirus (HPV) DNA for females |
45,00 |
17190 |
Detection of low risk types of human papillomavirus (HPV) DNA for females |
45,00 |
17191 |
Detection of low-risk types of human papillomavirus (HPV) DNA for males |
47,00 |
17192 |
Detection of high-risk types of human papillomavirus (HPV) DNA for males |
47,00 |
17193 |
Detection of T.gondii IgM by enzyme immunoassay |
17,00 |
17194 |
Detection of T.gondii IgG by enzyme immunoassay |
38,00 |
17195 |
Detection of T.gondii IgA by enzyme immunoassay |
15,00 |
17196 |
Detection of T.gondii IgM by immunosorbent agglutination assay |
28,00 |
17197 |
Detection of T.gondii IgA by immunosorbent agglutination assay |
28,00 |
17198 |
Detection of T.gondii IgG avidity testing by enzyme immunoassay |
43,00 |
17199 |
Detection of T.gondii IgG by immunoblotting |
65,00 |
17200 |
Detection of T.gondii IgM by immunoblotting |
65,00 |
17201 |
Detection of Toxocara canis IgG/IgM by enzyme immunoassay |
13,00 |
17202 |
Detection of Toxocara canis IgG/IgM by immunoblotting |
63,00 |
17203 |
Detection of Toxocara canis IgM antibodies by enzyme immunoassay |
18,00 |
17204 |
Detection of Toxocara canis IgG antibodies by enzyme immunoassay |
16,00 |
17205 |
Detection of Trichinella spiralis IgG by enzyme immunoassay |
17,00 |
17206 |
Detection of Trichinella spiralis by immunoblotting |
63,00 |
17207 |
Detection of Echinococcus (granulosus) by enzyme immunoassay |
45,00 |
17208 |
Detection of Echinococcus (granulosus, multilocularis) by immunoblotting |
63,00 |
17209 |
Detection of Echinococcus multilocularis by enzyme immunoassay |
48,00 |
17210 |
Detection of Cysticercus cellulosus IgG by enzyme immunoassay |
17,00 |
17211 |
Detection of giardiasis from stools by enzyme immunoassay |
17,00 |
17212 |
Detection of Treponema pallidum by darkfield microscopy |
9,00 |
17213 |
Detection of Treponema pallidum by direct immunofluorescence assay |
13,00 |
17214 |
Detection of Treponema pallidum IgM/IgG by enzyme immunoassay |
7,00 |
17215 |
Treponema pallidum IgM by enzyme immunoassay |
12,00 |
17216 |
Treponema pallidum IgG enzyme immunoassay |
12,00 |
17217 |
Treponema pallidum IgG, IgM immunoblotting |
49,00 |
17218 |
RPR qualitative reaction |
3,00 |
17219 |
RPR semi-quantitative reaction |
3,00 |
17220 |
TPHA- qualitative Treponema pallidum particle agglutination assay |
3,00 |
17221 |
TPHA- quantitative Treponema pallidum particle agglutination assay |
4,00 |
17222 |
VDRL CSF – syphilis detection in cerebrospinal fluid |
3,00 |
17223 |
Detection of Borrelia (Lyme disease) IgG antibodies by enzyme immunoassay |
12,00 |
17224 |
Detection of Borrelia (Lyme disease) IgM antibodies by enzyme immunoassay |
12,00 |
17225 |
Detection of Borrelia (Lyme disease) IgG/IgM (general antibodies) by enzyme immunoassay |
14,00 |
17226 |
Detection of Borrelia (Lyme disease) IgG antibodies by immunoblotting |
47,00 |
17227 |
Detection of Borrelia (Lyme disease) IgM antibodies by immunoblotting |
47,00 |
17228 |
Examination of Borrelia (Lyme disease) DNA |
37,00 |
17229 |
Detection of neuroborreliosis IgG/IgM antibodies in cerebrospinal fluid and serum by enzyme immunoassay |
53,00 |
17230 |
Detection of specific intrathecal IgG (gradient) by enzyme immunoassay |
11,00 |
17231 |
Detection of Aspergillus antigen (Galaktomanan) by enzyme immunoassay |
17,00 |
17232 |
Detection of Candida antigen (Mannan) by enzyme immunoassay |
17,00 |
17703 |
Genital swab for S. agalactiae, negative |
8,00 |
17704 |
Genital swab S. agalactiae, positive |
10,00 |
17705 |
Identification of fungi (non Candida) |
7,00 |
17707 |
Identification of plasma non-coagulating staphylococcus |
8,00 |
17713 |
Procalcitonin test |
27,00 |
30009 |
Cytopathlogy diagnostic test (vaginal and cervical), according to Bethesda system (oncocytology test) |
12,00 |
17708 |
Examination of laryngeal, nasal and ear smear for identification of fungus pathogen |
4,00 |
17709 |
Examination of laryngeal, nasal and ear smear for eosinophils |
4,00 |
17710 |
Thin Prep PAP test |
45,00 |
17711 |
Chlamydia trachomatis PCR |
14,00 |
17712 |
Candida albicans PCR |
16,00 |
17713 |
Candida albicans, Candida glabrata, Candida krusei PRR |
22,00 |
17714 |
Mycoplasma hominis PCR |
15,00 |
17715 |
Mycoplasma genitalium PCR |
15,00 |
17716 |
Ureaplasma spp. PCR |
16,00 |
17717 |
Gardnerella vaginalis PCR |
15,00 |
17718 |
Trichomonas vaginalis PCR |
16,00 |
17719 |
Neisseria gonorrhoeae PCR |
16,00 |
17720 |
Herpes Simplex virus (HSV) PCR |
15,00 |
17721 |
Chl. tracomatis, Myc. genitalium, Ureaplasma DNA RT PCR |
40,00 |
17722 |
Chl. tracomatis, Myc. genitalium, Ureaplasma DNA RT PCR in urine |
45,00 |
17723 |
Chl. tracomatis, Myc. hominis, Ureaplasma DNA RT PCR |
49,00 |
17724 |
Chl. tracomatis, Myc. hominis, Ureaplasma DNA RT PCR in urine |
55,00 |
17725 |
Chlamydia tracomatis, or Mycoplasma genitalium or Mycoplasma hominis or Neisseria gonorrhoeae or Trichomonas vaginalis or Ureaplasma spp. arba Gardnerella vaginalis PCR in urine |
15,00 |
17726 |
Detection of human papillomavirus HPV and HPV genotypes 16, 18, 31, 33, 39, 45, 51, 52, 56, 58, 59 by PCR |
55,00 |
17727 |
Detection of human papillomavirus HPV genotypes 16 and 18 by PCR |
36,00 |
17728 |
Detection of human papillomavirus HPV genotypes 6 and 11 by PCR |
20,00 |
17729 |
Detection of Cryptosporodium parvum in stool samples (Crypto-Strip test) |
5,00 |
17730 |
Group B streptococcus test |
6,00 |
17731 |
Influenza A and B virus detection by express method |
12,00 |
17732 |
Bacterial vaginosis PCR |
26,00 |
17733 |
Candida albicans PCR |
26,00 |
17734 |
OPTIGEN (20 allergens) |
49,00 |